HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prophylactic antibiotics for cesarean section: comparison of high- and low-risk patients for endomyometritis.

Abstract
The efficacy of ticarcillin in the prevention of post-cesarean section endomyometritis was studied in 259 women randomly given either the antibiotic or a placebo. The ticarcillin group received 6 g intravenously immediately after delivery. Then 22 of those patients were also given a second 3-g dose 6 to 8 hours after delivery. Among the 139 patients who received ticarcillin, endomyometritis developed in 44 (32%), as it did in 66 of 120 patients (55%) in the placebo group. These differences are highly significant (P = .002). Of the 259 patients in the study, 238 could be classified as to risk for endomyometritis developing. Among the 124 high-risk patients, 52 received a placebo and endomyometritis developed in 71%. Only 26 of the 72 high-risk patients who received ticarcillin (36%) were so infected. Among the low-risk patients, endomyometritis developed in 10 of 54 patients (18.5%) who received prophylaxis and in 24 of 60 patients who received placebo (40%). Ticarcillin appears to be effective in reducing the incidence of post-cesarean section endomyometritis in patients at high risk and in those at low risk. The number of pelvic examinations during labor was the most important single factor in the development of endomyometritis.
AuthorsJ J Apuzzio, C Reyelt, M Pelosi, P Sen, D B Louria
JournalObstetrics and gynecology (Obstet Gynecol) Vol. 59 Issue 6 Pg. 693-8 (Jun 1982) ISSN: 0029-7844 [Print] United States
PMID7043345 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Penicillins
  • Ticarcillin
Topics
  • Adult
  • Age Factors
  • Cesarean Section
  • Clinical Trials as Topic
  • Endometritis (prevention & control)
  • Female
  • Fetal Membranes, Premature Rupture
  • Humans
  • Labor, Obstetric
  • Penicillins (therapeutic use)
  • Physical Examination
  • Pregnancy
  • Premedication
  • Random Allocation
  • Risk
  • Ticarcillin (therapeutic use)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: